Brick & Kyle Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,527
Closed -$123K 245
2017
Q1
$123K Hold
1,527
0.1% 112
2016
Q4
$109K Sell
1,527
-66
-4% -$5.18K 0.09% 118
2016
Q3
$138K Sell
1,593
-240
-13% -$20.9K 0.11% 106
2016
Q2
$159K Buy
1,833
+133
+8% +$10.8K 0.13% 98
2016
Q1
$128K Hold
1,700
0.11% 106
2015
Q4
$131K Hold
1,700
0.12% 104
2015
Q3
$114K Hold
1,700
0.11% 115
2015
Q2
$126K Hold
1,700
0.11% 119
2015
Q1
$133K Buy
+1,700
New +$129K 0.11% 114

Other funds holding MDT

Brick & Kyle Associates's MDT Position: Q2 2017 in Review

Brick & Kyle Associates sold out of Medtronic (MDT) in Q2 2017, closing a stake of 1,527 shares — an estimated $123K sold.

Brick & Kyle Associates first reported a position in MDT in Q1 2015 and held it in 9 quarters. The position peaked at $159K in Q2 2016. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Brick & Kyle Associates reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • Brick & Kyle Associates sold 1,527 Medtronic shares in Q2 2017, an estimated $123K.
  • Brick & Kyle Associates first reported a position in Medtronic in Q1 2015 and held it in 9 quarters.
  • Brick & Kyle Associates's Medtronic position peaked at $159K in Q2 2016.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Brick & Kyle Associates's 13F filing for Q2 2017, filed 14 Aug 2017.